Four JP Drafts Related to Balances Published for Public Comments
Recommendation
3/4 February 2026
Evaluation, Implementation and Use of Suitable Technologies
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has announced the availability of four Japanese Pharmacopoeia (JP) drafts of General Tests and General Information related to Balances.
The following documents have been published on the PMDA website:
- Draft of revised General Test “<9.62> Measuring Instruments, Appliances”
- Draft of new General Information “<G1-6-182> Concept of Weighing in the Japanese Pharmacopoeia”
- Draft of new General Information “<G1-7-182> Calibration, Inspection, and Weight of a weighing instrument (balance)”
- Draft of new General Information “<G1-8-182> Installation Environment, Basic Handling Method, and Precautions for Weighing of a Balance”
The PMDA also published a Briefing Note in which the key points of these four drafts are summarised. It is pointed out that the drafts "were developed by referring to the content and requirements provided in United States Pharmacopeia and European Pharmacopoeia."
It is planned to include the chapters in Supplement II to the Japanese Pharmacopoeia 18th edition.
Comments can be submitted until 31 March 2023. For this purpose, a form for comments has to be downloaded and sent by e-mail after it has been filled in.
Related GMP News
18.12.2025FDA Form 483: Excel-Based Data Falsification and Duplicate Log Books
18.12.2025Questions and Answers on System Suitability Tests (SST) - Part 1
18.12.2025PharmaLab 2025: Brief Summary of AQCG Track - Save the Date for 2026!
18.12.2025FDA Warning Letter: 1,500 OOS Results with Numerous Inadequate Investigations
17.12.2025FDA Warning Letter Criticises Handling of OOS Results at a Contract Laboratory
17.12.2025FDA Warning: No Recall Conducted Despite Confirmed Benzene Impurity